Longitudinal analyses of medication adherence data in hiv-infected illicit drug users

It has been long established that adherence to highly active antiretroviral therapy (HAART) is extremely important for therapeutic outcomes for the treatment of HIV-infection. With the advent of HAART, decreases in morbidity and mortality have been observed in HIVinfected individuals. However, these...

Full description

Bibliographic Details
Main Author: Raffa, Jesse Daniel
Language:English
Published: 2010
Online Access:http://hdl.handle.net/2429/18114
id ndltd-UBC-oai-circle.library.ubc.ca-2429-18114
record_format oai_dc
spelling ndltd-UBC-oai-circle.library.ubc.ca-2429-181142018-01-05T17:39:14Z Longitudinal analyses of medication adherence data in hiv-infected illicit drug users Raffa, Jesse Daniel It has been long established that adherence to highly active antiretroviral therapy (HAART) is extremely important for therapeutic outcomes for the treatment of HIV-infection. With the advent of HAART, decreases in morbidity and mortality have been observed in HIVinfected individuals. However, these decreases have not generally been extended to injection drug users (IDUs) whom have additional barrier to access HAART, including adherence. Strategies such as directly observed therapy (DOT) have been successful in treating IDUs, especially when they are used in conjunction with methadone maintenance programs. Within these programs HAART and methadone are co-administered, which makes it possible to estimate HAART adherence through a surrogate, methadone adherence. With this in mind we sought to assess if ongoing illicit drug use within such a program would affect methadone adherence. Decreased methadone adherence was noted during periods of opiate use. Furthermore, we sought to assess the relationships between HAART adherence and each of virologic suppression and the emergence of drug resistance mutations. In the former, robust rates of virologic suppression were observed at every adherence level during maintenance therapy with the exception of the 80-90% adherence level where higher rates of virologic failure were observed. This may be explained by a phenomena observed when assessing the latter where higher rates of the accumulation of new drug resistance mutations were observed at the 80-90% level. Although this intermediate level of adherence has been previously described, the estimated range of adherence values reported in this thesis is much narrower than those reported in the literature. All such analyses were conducted in a longitudinal framework, with data analysis done using generalized estimating equations (GEE). Although a cross-sectional approach is typically conducted for these types of studies, a longitudinal approach is better able to localize the outcomes (e.g. virologic suppression) to the periods and patterns of non-adherence. This may explain some of the differences found in the studies contained in this thesis which may disagree with the findings in previous reports. With this in mind, it may be important to look at adherence to HAART in a more insightful manner than has been traditionally done. Science, Faculty of Statistics, Department of Graduate 2010-01-13T00:49:20Z 2010-01-13T00:49:20Z 2006 2006-11 Text Thesis/Dissertation http://hdl.handle.net/2429/18114 eng For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
collection NDLTD
language English
sources NDLTD
description It has been long established that adherence to highly active antiretroviral therapy (HAART) is extremely important for therapeutic outcomes for the treatment of HIV-infection. With the advent of HAART, decreases in morbidity and mortality have been observed in HIVinfected individuals. However, these decreases have not generally been extended to injection drug users (IDUs) whom have additional barrier to access HAART, including adherence. Strategies such as directly observed therapy (DOT) have been successful in treating IDUs, especially when they are used in conjunction with methadone maintenance programs. Within these programs HAART and methadone are co-administered, which makes it possible to estimate HAART adherence through a surrogate, methadone adherence. With this in mind we sought to assess if ongoing illicit drug use within such a program would affect methadone adherence. Decreased methadone adherence was noted during periods of opiate use. Furthermore, we sought to assess the relationships between HAART adherence and each of virologic suppression and the emergence of drug resistance mutations. In the former, robust rates of virologic suppression were observed at every adherence level during maintenance therapy with the exception of the 80-90% adherence level where higher rates of virologic failure were observed. This may be explained by a phenomena observed when assessing the latter where higher rates of the accumulation of new drug resistance mutations were observed at the 80-90% level. Although this intermediate level of adherence has been previously described, the estimated range of adherence values reported in this thesis is much narrower than those reported in the literature. All such analyses were conducted in a longitudinal framework, with data analysis done using generalized estimating equations (GEE). Although a cross-sectional approach is typically conducted for these types of studies, a longitudinal approach is better able to localize the outcomes (e.g. virologic suppression) to the periods and patterns of non-adherence. This may explain some of the differences found in the studies contained in this thesis which may disagree with the findings in previous reports. With this in mind, it may be important to look at adherence to HAART in a more insightful manner than has been traditionally done. === Science, Faculty of === Statistics, Department of === Graduate
author Raffa, Jesse Daniel
spellingShingle Raffa, Jesse Daniel
Longitudinal analyses of medication adherence data in hiv-infected illicit drug users
author_facet Raffa, Jesse Daniel
author_sort Raffa, Jesse Daniel
title Longitudinal analyses of medication adherence data in hiv-infected illicit drug users
title_short Longitudinal analyses of medication adherence data in hiv-infected illicit drug users
title_full Longitudinal analyses of medication adherence data in hiv-infected illicit drug users
title_fullStr Longitudinal analyses of medication adherence data in hiv-infected illicit drug users
title_full_unstemmed Longitudinal analyses of medication adherence data in hiv-infected illicit drug users
title_sort longitudinal analyses of medication adherence data in hiv-infected illicit drug users
publishDate 2010
url http://hdl.handle.net/2429/18114
work_keys_str_mv AT raffajessedaniel longitudinalanalysesofmedicationadherencedatainhivinfectedillicitdrugusers
_version_ 1718590733816954880